tiprankstipranks
Trending News
More News >
Celcuity (CELC)
NASDAQ:CELC
US Market

Celcuity (CELC) Stock Forecast & Price Target

Compare
283 Followers
See the Price Targets and Ratings of:

CELC Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Celcuity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CELC Stock 12 Month Forecast

Average Price Target

$28.25
▲(109.10%Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Celcuity in the last 3 months. The average price target is $28.25 with a high forecast of $30.00 and a low forecast of $27.00. The average price target represents a 109.10% change from the last price of $13.51.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","31":"$31","13.75":"$13.75","19.5":"$19.5","25.25":"$25.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$28.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,13.75,19.5,25.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.49,13.836923076923076,15.183846153846154,16.53076923076923,17.877692307692307,19.224615384615383,20.57153846153846,21.918461538461536,23.265384615384612,24.612307692307688,25.959230769230764,27.306153846153844,28.653076923076924,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.49,13.702307692307693,14.914615384615384,16.126923076923077,17.33923076923077,18.551538461538463,19.763846153846153,20.976153846153846,22.18846153846154,23.40076923076923,24.613076923076925,25.825384615384614,27.03769230769231,{"y":28.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.49,13.606153846153846,14.722307692307693,15.838461538461537,16.954615384615384,18.07076923076923,19.186923076923076,20.303076923076922,21.41923076923077,22.535384615384615,23.65153846153846,24.767692307692307,25.88384615384615,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.3,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.64,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.94,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.58,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.93,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.63,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.95,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.43,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.29,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.62,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$30.00Average Price Target$28.25Lowest Price Target$27.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CELC
Stephen WilleyStifel Nicolaus
Stifel Nicolaus
$30
Buy
122.06%
Upside
Initiated
07/01/25
Celcuity resumed with a Buy at StifelCelcuity resumed with a Buy at Stifel
Craig-Hallum
Buy
Reiterated
06/30/25
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Clene (CLNN)
LifeSci Capital Analyst forecast on CELC
Oliver McCammonLifeSci Capital
LifeSci Capital
$27
Buy
99.85%
Upside
Reiterated
06/30/25
Promising Preliminary Data and Positive Outlook for Celcuity's Gedatolisib in Cancer Trials
Leerink Partners Analyst forecast on CELC
Andrew BerensLeerink Partners
Leerink Partners
Buy
Reiterated
06/30/25
Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating for Celcuity's Gedatolisib
Needham Analyst forecast on CELC
Gil BlumNeedham
Needham
$29
Buy
114.66%
Upside
Reiterated
06/30/25
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), BioNTech SE (NASDAQ: BNTX) and Soleno Therapeutics (NASDAQ: SLNO)
H.C. Wainwright Analyst forecast on CELC
Swayampakula RamakanthH.C. Wainwright
H.C. Wainwright
$27
Buy
99.85%
Upside
Reiterated
05/19/25
Celcuity's Promising Clinical Trials and Strong Financial Position Justify Buy Rating
TD Cowen
Buy
Reiterated
05/14/25
Celcuity's Gedatolisib Phase III Trial and Market Potential Drive Buy Rating
Jefferies
$28$33
Buy
144.26%
Upside
Reiterated
01/23/25
Celcuity Inc (CELC) PT Raised to $33 at JefferiesJefferies analyst Maury Raycroft raised the price target on Celcuity Inc (NASDAQ: CELC) to $33.00 (from $28.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CELC
Stephen WilleyStifel Nicolaus
Stifel Nicolaus
$30
Buy
122.06%
Upside
Initiated
07/01/25
Celcuity resumed with a Buy at StifelCelcuity resumed with a Buy at Stifel
Craig-Hallum
Buy
Reiterated
06/30/25
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Clene (CLNN)
LifeSci Capital Analyst forecast on CELC
Oliver McCammonLifeSci Capital
LifeSci Capital
$27
Buy
99.85%
Upside
Reiterated
06/30/25
Promising Preliminary Data and Positive Outlook for Celcuity's Gedatolisib in Cancer Trials
Leerink Partners Analyst forecast on CELC
Andrew BerensLeerink Partners
Leerink Partners
Buy
Reiterated
06/30/25
Promising Clinical Trial Results and Favorable Safety Profile Drive Buy Rating for Celcuity's Gedatolisib
Needham Analyst forecast on CELC
Gil BlumNeedham
Needham
$29
Buy
114.66%
Upside
Reiterated
06/30/25
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), BioNTech SE (NASDAQ: BNTX) and Soleno Therapeutics (NASDAQ: SLNO)
H.C. Wainwright Analyst forecast on CELC
Swayampakula RamakanthH.C. Wainwright
H.C. Wainwright
$27
Buy
99.85%
Upside
Reiterated
05/19/25
Celcuity's Promising Clinical Trials and Strong Financial Position Justify Buy Rating
TD Cowen
Buy
Reiterated
05/14/25
Celcuity's Gedatolisib Phase III Trial and Market Potential Drive Buy Rating
Jefferies
$28$33
Buy
144.26%
Upside
Reiterated
01/23/25
Celcuity Inc (CELC) PT Raised to $33 at JefferiesJefferies analyst Maury Raycroft raised the price target on Celcuity Inc (NASDAQ: CELC) to $33.00 (from $28.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Celcuity

1 Month
xxx
Success Rate
3/7 ratings generated profit
43%
Average Return
+0.97%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of +0.97% per trade.
3 Months
xxx
Success Rate
4/7 ratings generated profit
57%
Average Return
+5.41%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +5.41% per trade.
1 Year
Success Rate
5/7 ratings generated profit
71%
Average Return
+4.37%
reiterated a buy rating 11 days ago
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +4.37% per trade.
2 Years
xxx
Success Rate
5/7 ratings generated profit
71%
Average Return
+6.73%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +6.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CELC Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
2
8
11
13
7
Buy
2
2
5
5
5
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
10
16
18
12
In the current month, CELC has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CELC average Analyst price target in the past 3 months is 28.25.
Each month's total comprises the sum of three months' worth of ratings.

CELC Financial Forecast

CELC Earnings Forecast

Next quarter’s earnings estimate for CELC is -$0.88 with a range of -$0.99 to -$0.78. The previous quarter’s EPS was -$0.86. CELC beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year CELC has Preformed in-line its overall industry.
Next quarter’s earnings estimate for CELC is -$0.88 with a range of -$0.99 to -$0.78. The previous quarter’s EPS was -$0.86. CELC beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year CELC has Preformed in-line its overall industry.
No data currently available

CELC Sales Forecast

Next quarter’s sales forecast for CELC is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. CELC beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year CELC has Preformed in-line its overall industry.
Next quarter’s sales forecast for CELC is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. CELC beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year CELC has Preformed in-line its overall industry.

CELC Stock Forecast FAQ

What is CELC’s average 12-month price target, according to analysts?
Based on analyst ratings, Celcuity’s 12-month average price target is 28.25.
    What is CELC’s upside potential, based on the analysts’ average price target?
    Celcuity has 109.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CELC a Buy, Sell or Hold?
          Celcuity has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Celcuity’s price target?
            The average price target for Celcuity is 28.25. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $30.00 ,the lowest forecast is $27.00. The average price target represents 109.10% Increase from the current price of $13.51.
              What do analysts say about Celcuity?
              Celcuity’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of CELC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis